SCHEMBL7266022

SCHEMBL7266022

CN(C(=O)CN)C(C)(Cc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ RECQL P46063 1/20 0.56
▸ MAPK1 P28482 1/20 0.55
▸ CYP2C19 P33261 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ HIF1A Q16665 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ SCN1A P35498 1/20 0.46
▸ SCN2A Q99250 1/20 0.46
▸ SCN3A Q9NY46 1/20 0.46
▸ AOC3 Q16853 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ RAB9A P51151 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL7267250 0.93 CYP3A4 (0.50) CYP1A2CYP3A4RECQLMAPK1CYP2C19
Fumaric Acid SCHEMBL7267252 0.93 CYP3A4 (0.50) CYP1A2CYP3A4RECQLMAPK1CYP2C19
Hydrochloric Acid SCHEMBL9511381 0.85 MAPK1 (0.56) CYP1A2CYP3A4RECQLMAPK1CYP2C19
SCHEMBL7273963 0.84 KMT2A (0.46) CYP1A2CYP3A4RECQLMAPK1CYP2C19
Hydrochloric Acid SCHEMBL9678356 0.81 MAPK1 (0.48) CYP1A2CYP3A4RECQLMAPK1CYP2C19
SCHEMBL10561803 0.80 CYP3A4 (0.48) CYP1A2CYP3A4RECQLMAPK1CYP2C19
SCHEMBL9512547 0.76 CYP3A4 (0.54) CYP1A2CYP3A4RECQLMAPK1CYP2C19
Hydrochloric Acid SCHEMBL9172426 0.74 MAPK1 (0.47) CYP1A2CYP3A4RECQLMAPK1CYP2C19
SCHEMBL27661323 0.74 TAAR1 (0.50) CYP1A2CYP3A4RECQLMAPK1CYP2C19
SCHEMBL9776961 0.74 CHRM1 (0.44) CYP1A2CYP3A4RECQLMAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279937-B1 2-AMINOACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1991-10-09 — — EP claimed
EP-0427427-A2 Use of arylalkylamides in the treatment of neurodegenerative diseases FISONS CORPORATION (US) 1991-05-15 — — EP claimed
EP-0427427-A2 Use of arylalkylamides in the treatment of neurodegenerative diseases FISONS CORPORATION (US) 1991-05-15 — — EP disclosed
Send feedback